Quality of life in adult hematopoietic cell transplant patients at least 5 yr after treatment: A comparison with healthy controls

European Journal of Haematology

Volumn 74, Issue 4, 2005, Pages 304-308

  Kopp, Martin ^a,c   Holzner, Bernhard ^a   Meraner, Verena ^a   Sperner Unterweger, Barbara ^a   Kemmler, Georg ^a   Nguyen Van Tam, Dominic P ^b   Nachbaur, David ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

EORTC QLQ C30; Healthy controls; Hematopoietic cell transplantation; Quality of life

Indexed keywords

ADULT; ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; EUROPEAN GROUP OF RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE QUESTIONNAIRE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LONG TERM CARE; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANK SUM TEST; SOCIAL INTERACTION;

ADULT; AUSTRIA; CASE-CONTROL STUDIES; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; TIME FACTORS;

EID: 16244422004     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2004.00402.x     Document Type: Article

References (33)

1. GRATWOHL A, BALDOMERO H, PASSWEG J. et al. Hematopoietic stem cell transplantation for hematological malignancies in Europe. Leukemia 2003;17:941-959.
2. ANDRYKOWSKI MA, ALTMAIER EM, BARNETT RL, OTIS ML, GINGRICH R, HENSLEE DOWNEY PJ. Psychosocial factors in bone marrow transplantation: a review and recommendations for research. Bone Marrow Transpl 1994;13:357-375.
3. VOSE JM, KENNEDY BC, BIERMAN PJ, KESSINGER A, ARMITAGE JO. Long-term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignancies. Cancer 1992;69:784-789.
4. MICALLEF IN, ROTHAINER AZS, CARTER M. Long-term outcome of patients surviving for more than ten years following treatment for acute leukemia. Br J Haematol. 2001;113:443-445.
5. WOLCOTT DL, WELLISCH DK, FAWZY FI, LANDVERK J. Adaptation of adult bone marrow transplant recipient long-term survivors. Transplantation 1986;41:478.
6. WOLCOTT DL, WELLISCH DK, FAWZY FI, LANDVERK J. Psychological adjustment of adult bone marrow transplantation donors whose recipient survive. Transplantation 1986;41:484.
7. KISS TL, ABDOLELL M, JAMAL N, MINDEN MD, LIPTON JH, MESSNER HA. Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation. J Clin Oncol 2002;20:2334-2343.
8. CHIODI S, SPINELLI S, RAVERA G, et al. Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematol 2000;110:614-619.
9. SYRJALA KL, LANGER SL, ABRAMS JR, STORER B, SANDERS JE, FLOWERS ME, MARTIN PJ. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA 2004;291:2335-2343.
10. TESTA MA, SIMONSON DC. Assessment of Quality-of-Life outcomes. N Engl J Med 1996;334:835-840.
11. AARONSON NK, AHMEDZAI S, BERGMAN B, et al. The European Organization for research and Treatment of Cancer QLQ-30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:364-376.
12. CELLA DF, TULSKY DS, GRAY G, et al. The Functional Assessment of Cancer Therapy Scale: development and validation of the general measure. J Clin Oncol 1993;11:570-579.
13. ALTMAIER EM, GINGRICH RD, FYFE MA. Two-year adjustment of bone marrow transplant survivors. Bone Marrow Transplant 1991;7:311-316.
14. ANDRYKOWSKI MA, ALTMAIER EM, BARNETT RL, RURISH TG, GINGRICH R, HENSLEE DOWNEY PJ. Cognitive dysfunction in adult survivors of allogeneic marrow transplantation: relationship to dose of total body irradiation. Bone Marrow Transplant 1990;6:269-276.
15. BAKER F, CURBOW B, WINGARD JR. Role retention and quality of life of bone marrow transplant survivors. Soc Sci Med 1991;36:697-704.
16. BELEC RH. Quality of life: perceptions of long-term survivors of bone marrow transplantation. Oncol Nurs Forum 1992;19:31-37.
17. HENGEVELD MW, HOUTMAN RB, ZWAAN FE. Psychological aspects of bone marrow transplantation: a retrospective study of 17 long-term survivors. Bone Marrow Transplant 1988;3:69-75.
18. HJERMSTAD MJ, KAASA, S. Quality of life in adult cancer patients treated with bone marrow transplantation - a review of the literature. Eur J Cancer 1995;31:163-173.
19. SCHMIDT GM, NILAND JC, FORMAN SJ, et al. Extended follow-up in 212 long-term allogeneic bone marrow transplant survivors. Issues of quality of life. Transplantation 1993;55:551-557.
20. SYRJALA KL, CHAPKO MK, VITALIANO PP, CUMMINGS C, SULLIVAN KM. Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. Bone Marrow Transplant 1993;11:319-327.
21. ZIGMOND A and SNAITH R. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-370.
22. HERRMANN C. International experiences with the Hospital Anxiety and Depression Scale - a review of validation data and clinical results. J Psychosom Res 1997;1:17-41.
23. SPINHOEVEN PH, ORMEL J, SLOCKERS PA, et al. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 1997;27:363-370.
24. JOHNSTON M, POLLARD B, HENNESSEY P. Construct validation of the hospital anxiety and depression scale with clinical populations. J Psychosom Res 2000;48:579-584.
25. WATSON M, GREEK S, YOUNG J, INAYAT Q, BURGESS C, ROBERTSON B. Development of a questionnaire measure of adjustment to cancer: the MAC scale. Psychol Med 1988;18:203-209.
26. GREER S, MOOREY S, WATSON M. Patients adjustment to cancer (MAC) scale vs. clinical ratings. J Psychosom Res 1989;33:373-377.
27. NORDIN K, BERGLUND G, TERJE I, GLIMELIUS B. The Mental Adjustment to Cancer Scale - A Psychometric Analysis and the Concept of Coping. Psychooncology 1999;8:250-259.
28. ROTHMAN KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43-46.
29. KEMMLER G, HOLZNER B, KOPP M, DÜNSER M, MARGREITER R, GREIL R, SPERNER-UNTERWEGER B. Comparison of two quality of life instruments for cancer patients. FACT-G and EORTC QLQ-C30. J Clin Oncol 1999;17:2932-2940.
30. HOLZNER B, KEMMLER G, SPERNER-UNTERWEGER B, KOPP M, DÜNSER M, MARGREITER R, MARSCHITZ I, NACHBAUR D, FLEISCHHACKER WW, GREIL R. Quality of life measurement in oncology - a matter of the assessment instrument?. Eur J Cancer 2001;37:2349-2356.
31. OSOBA D. Clinical meaningfulness (CM) of differences in health-related quality of life scores in clinical trials. Qual Life Res, 2000;9:256.
32. KOPP M, SCHWEIGKOFLER H, HOLZNER B, NACHBAUR D, NIEDERWIESER D, FLEISCHHACKER WW, KEMMLER G, SPERNER-UNTERWEGER B. EORTC QLQ-C30 and FACT-BMT for the measurement of quality of life in bone marrow transplant recipients: a comparison. Eur J Haematol 2000;65:97-103.
33. CELLA D, HAHN EA, DINEEN K. Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening. Qual Life Res 2002;11:207-221.